Recently released market study: South Africa Pharmaceuticals & Healthcare Report Q4 2010

Oct. 14, 2010 - PRLog -- South Africa's pharmaceutical market was valued at ZAR20.4bn (US$2.4bn) in 2009. By 2014, we forecast that drug spending in the country will reach ZAR31.7bn (US$5.2bn), experiencing a 2009-2014 compound annual growth rate (CAGR) of 9.2% in local currency terms and 16.6% in US dollar terms. Over the extended 2009-2019 forecast period, we calculate that drugs spending will reach ZAR47.4bn (US$10.0bn), equating to a CAGR of 8.8% in local currency terms and 15.2% in US dollar terms.

South Africa's pharmaceutical business environment is rated as the second strongest in the Middle East and Africa region according to BMI's Q410 rankings. The country has a large pharmaceutical market with significant growth potential and this is reflected in the high score for the industry rewards indicator. A relatively stable political and economic environment means that South Africa also scores highly for the country risk indicator.

The country has Africa's strongest domestic pharmaceutical industry, with companies increasingly looking to neighbouring markets and further afield for growth. Pending shareholder approval and the completion of due diligence, South Africa's largest pharmaceutical company, Aspen, will acquire Australian pharmaceutical company Sigma's generic drug business for AUD900mn (US$811mn) in cash. The move represents further diversification from Aspen's core South African operations. Its home market's contribution to the total sales decreased from 77% in June 2008 to 56% in June 2009.

South Africa has a ZAR2bn (US$280mn) clinical research industry, largely focused on clinical trials of HIV/AIDS treatments. Multinational firms, including the US-based clinical research organisations (CROs) Parexel and Quintiles, dominate the market, although a number of local players such as Triclinium are emerging, encouraged by government support for the local biotech industry.

The country's public healthcare system continues to function in a state of disarray, with many hospitals understaffed or undersupplied with the appropriate medicines and equipment. In August 2010, it was reported that HIV and tuberculosis patients in the Eastern Cape province had not been receiving drugs as the local health department had not paid suppliers. Since March 2010, hospitals and clinics have been struggling to maintain adequate amounts of drugs, including antiretrovirals (ARV), because unpaid service providers have stopped supplies.

For more information or to purchase this report, go to:
-  http://www.fastmr.com/prod/87987_south_africa_pharmaceuti...

Report Table of Contents:

Executive Summary
SWOT Analysis
- South Africa Pharmaceuticals And Healthcare Industry SWOT
- South Africa Political SWOT
- South Africa Economic SWOT
- South Africa Business Environment SWOT
Pharmaceutical Business Environment Ratings
- Table: Middle East And Africa Pharmaceutical Business Environment Ratings, Q410
- Rewards
- Risks
South Africa - Market Summary
Regulatory Regime
- Table: South Africa Drug Classification System (Section 22A of the Medicines and Related Substance Act 101 of 1965)
- Regulatory Developments
- Table: Proposed Scope Of SAHPRA
- Pharmaceutical Advertising
- Intellectual Property Environment
- IP Developments
- Counterfeit Activity
- Pricing System
- Price Increases
- Pricing Developments
- Reimbursement System
Industry Developments
- Epidemiology
- HIV/AIDS
- Tuberculosis
- Healthcare Sector
- Healthcare Sector Developments
- Medical Tourism
- Private Healthcare Regulation
- National Health Reference Price List
- Health Insurance
- Government Health Insurance
- ARV Manufacturing And Government Tenders
- Pharmaceutical Sector Developments
- Retail Pharmacy Sector
- Research & Development Sector
- R&D Activities
- Vaccines
- Traditional African Medicine
- Medical Devices
- Table: South African Customs Classification Of Medical Devices
- Regional Developments In Medical Devices Sector
- Table: Aims Of PEPFAR-BD Partnership
Industry Forecast Scenario
- Overall Market Forecast
- Key Growth Factors - Industry
- Key Growth Factors - Macroeconomic
- Table: South Africa Economic Activity, 2007-2014
- Prescription Drug Market Forecast
- Patented Drug Market Forecast
- Generic Drug Market Forecast
- OTC Medicine Market Forecast
- Medical Device Market Forecast
- Pharmaceutical Trade Forecast
- Other Healthcare Data
- Key Risks To BMI's Forecast Scenario
Competitive Landscape
- Table: Private Market Size For Selected Products In South Africa (2007)
Company Profiles
- Indigenous Manufacturers
- Aspen
- Adcock Ingram
- Cipla-Medpro Africa
- Multinational Companies
- Sanofi-Aventis
- Pfizer
- Roche
- Ranbaxy
- GlaxoSmithKline
- Merck & Co
Country Snapshot: South Africa Demographic Data
- Section 1: Population
- Table: Demographic Indicators, 2005-2030
- Table: Rural/Urban Breakdown, 2005-2030
- Section 2: Education And Healthcare
- Table: Education, 2002-2005
- Table: Vital Statistics, 2005-2030
- Section 3: Labour Market and Spending Power
- Table: Employment Indicators, 2001-2006
- Table: Consumer Expenditure, 2000-2012 (US$)
- Table: Average Annual Wages, 2000-2012
BMI Methodology
- How We Generate Our Pharmaceutical Industry Forecasts
- Risk/Reward Ratings Methodology
- Ratings Overview
- Table: Pharmaceutical Business Environment Indicators
- Weighting
- Table: Weighting Of Components
- Sources
Forecast Tables

About Business Monitor International

Business Monitor International (BMI) offers a comprehensive range of products and services designed to help senior executives, analysts and researchers assess and better manage operating risks, and exploit business opportunities, across 175 markets.  BMI offers three main areas of expertise: Country Risk BMI's country risk and macroeconomic forecast portfolio includes weekly financial market reports, monthly regional Monitors, and in-depth quarterly Business Forecast Reports.  Industry Analysis BMI covers a total of 17 industry verticals through a portfolio of services, including in-depth quarterly Country Forecast Reports.  View more research from Business Monitor International at http://www.fastmr.com/catalog/publishers.aspx?pubid=1010

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

# # #

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.